Twist Bioscience Corp.

Stock ticker:

Before the market opened on November 15, 2022, Scorpion Capital issued a report on Twist Bioscience, describing the company as “a cash-burning inferno that is not a going concern, operating a ponzi-like scheme that will end in bankruptcy.” On this news shares of Twist Bioscience Corp. fell more than 30% in premarket trading on November 15, 2022.

Download Complaint

Are you a victim of corporate fraud?

Talk to us about your case.

Contact our attorneys for a no-cost case evaluation.